Lion's Mane and Alzheimer's Disease
Explore mushroom research and guides on lion's mane and alzheimer's disease.
Lion's Mane and Amyloid Beta: Mechanisms of Neuroprotection
Erinacine A reduces amyloid plaques in transgenic mice. Lion's mane also targets tau and neuroinflammation through separate compounds. Three mechanisms, all preclinical evidence reviewed.
Lion's Mane and MCI: What the Clinical Trials Show
Mori 2009 found lion's mane improved MCI scores over 16 weeks; effects reversed 4 weeks after stopping. What the clinical trials show and what they don't.
Lion's Mane and Alzheimer's Disease: What Research Shows
One 49-week pilot RCT in mild Alzheimer's patients showed higher MMSE and IADL scores versus placebo. The single small trial sits atop strong preclinical evidence targeting amyloid and neuroinflammation.
Lion's Mane for Elderly Cognitive Decline: Dosing Guide
Mori 2009 used 3g/day whole fruiting body. Li 2020 used 1.05g/day erinacine A-enriched mycelium. These preparations are not interchangeable. Critical dosing guide.